Recommended Topic Related To:

Oralair

"The U.S. Food and Drug Administration recently approved Oralair to treat allergic rhinitis (hay fever) with or without conjunctivitis (eye inflammation) that is induced by certain grass pollens in people ages 10 through 65 years. Oralair is the f"...

Oralair

OVERDOSE

No information provided.

CONTRAINDICATIONS

ORALAIR is contraindicated in patients with:

  • Severe, unstable or uncontrolled asthma
  • History of any severe systemic allergic reaction
  • History of any severe local reaction to sublingual allergen immunotherapy
  • Hypersensitivity to any of the inactive ingredients (mannitol, microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate and lactose monohydrate) contained in this product [see DESCRIPTION]

Last reviewed on RxList: 4/15/2014
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Allergies & Asthma

Improve treatments & prevent attacks.